Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiguo Wan

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
Clinical Rheumatology|October 28, 2021
Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 studyJinmei Su, Mengtao Li, Lan He, et al.
Annals of the Rheumatic Diseases|February 26, 2026
Efficacy and safety of mufemilast in patients with Behçet's syndrome: a phase 2 randomised clinical trialTian Liu, Chun Li, Wenjie Zheng, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
Clinical Rheumatology|October 28, 2021
Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 studyJinmei Su, Mengtao Li, Lan He, et al.
Annals of the Rheumatic Diseases|February 26, 2026
Efficacy and safety of mufemilast in patients with Behçet's syndrome: a phase 2 randomised clinical trialTian Liu, Chun Li, Wenjie Zheng, et al.
Pageof 9